Glomerulopathy, microvascular damage and aortic stiffness in patients with COPD Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018 Year: 2018
Borderline pulmonary hypertension was associated with reduced cardiac output during exercise in patients withconnective tissue diseases Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017
Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001
Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002
Arterial stiffness and endothelial dysfunction in stable COPD patients Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012
Sarcoidosis is associated with impaired endothelial function and arterial stiffness Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010
Comparison of exercise capacity, pulmonary functions, respiratory and peripheral muscle strength between patients with idiopathic pulmonary arterial hypertension and Eisenmenger syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Antithrombogenic activity of a vascular wall at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Assessment of the BODE index, arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012
Increased risk of peripheral arterial disease in individuals with COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017
Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and coronary artery disease Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015
Elevated pulmonary artery to aortic ratio measured with MRI identifies patients with pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 312s Year: 2005
Elevated pulmonary vascular resistance predicts mortality in COPD patients Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021 Year: 2021
Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007
Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012